Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

TinniStop introduced to offer relief to tinnitus sufferers

By TinniStop | March 7, 2017

Over 50 million Americans who suffer from the debilitating symptoms of tinnitus can now find relief. TinniStop announced a new patent-pending medicine that relieves the ringing, buzzing and clicking in the ears. Thenatural medicine combines three little-known homeopathic remedies proven over decades to be highly effective. TinniStop has no side effects and requires no prescription. It is manufactured by an FDA-registered laboratory in the U.S.

Tinnitus, the hearing of sound when no external sound is present, is a chronic condition most frequently caused by years of exposure to loud noise. The Mayo Clinic estimates that over 20 percent of Americans suffer from tinnitus. There is no medical cure.

TinniStop’s product is based on homeopathic medicine — natural remedies made from highly diluted extracts of plants and minerals. The company says that the three ingredients in TinniStop have been shown, through decades of clinical use, to be effective in alleviating the symptoms of tinnitus. Conium maculatum reportedly relieves humming and buzzing, causticum is said to relieve ringing and roaring, and cocculus indicus reportedly relieves noise sensitivity.

FTC disputes that homeopathic treatments are effective.

(Source: PR Newswire)


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50